Free Trial

Alphatec (ATEC) Competitors

Alphatec logo
$9.93 +0.36 (+3.76%)
(As of 11/20/2024 ET)

ATEC vs. MDXG, LMNX, GNMK, CRY, ITGR, ATRC, IART, OFIX, SRDX, and ANGO

Should you be buying Alphatec stock or one of its competitors? The main competitors of Alphatec include MiMedx Group (MDXG), Luminex (LMNX), GenMark Diagnostics (GNMK), CryoLife (CRY), Integer (ITGR), AtriCure (ATRC), Integra LifeSciences (IART), Orthofix Medical (OFIX), Surmodics (SRDX), and AngioDynamics (ANGO). These companies are all part of the "medical" sector.

Alphatec vs.

MiMedx Group (NASDAQ:MDXG) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their community ranking, valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

MiMedx Group has higher earnings, but lower revenue than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MiMedx Group$321.48M4.14$58.23M$0.5516.47
Alphatec$482.26M2.92-$186.64M-$1.28-7.76

In the previous week, Alphatec had 1 more articles in the media than MiMedx Group. MarketBeat recorded 10 mentions for Alphatec and 9 mentions for MiMedx Group. Alphatec's average media sentiment score of 0.72 beat MiMedx Group's score of 0.50 indicating that Alphatec is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MiMedx Group
1 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alphatec
4 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

79.2% of MiMedx Group shares are owned by institutional investors. Comparatively, 66.4% of Alphatec shares are owned by institutional investors. 1.3% of MiMedx Group shares are owned by company insiders. Comparatively, 22.8% of Alphatec shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

MiMedx Group presently has a consensus price target of $12.00, suggesting a potential upside of 32.45%. Alphatec has a consensus price target of $17.11, suggesting a potential upside of 72.32%. Given Alphatec's higher possible upside, analysts clearly believe Alphatec is more favorable than MiMedx Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MiMedx Group
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
Alphatec
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89

Alphatec received 284 more outperform votes than MiMedx Group when rated by MarketBeat users. However, 81.82% of users gave MiMedx Group an outperform vote while only 57.72% of users gave Alphatec an outperform vote.

CompanyUnderperformOutperform
MiMedx GroupOutperform Votes
45
81.82%
Underperform Votes
10
18.18%
AlphatecOutperform Votes
329
57.72%
Underperform Votes
241
42.28%

MiMedx Group has a net margin of 23.86% compared to Alphatec's net margin of -31.06%. MiMedx Group's return on equity of 26.21% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
MiMedx Group23.86% 26.21% 18.15%
Alphatec -31.06%-541.39%-22.99%

MiMedx Group has a beta of 1.94, meaning that its share price is 94% more volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500.

Summary

MiMedx Group beats Alphatec on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATEC vs. The Competition

MetricAlphatecSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.36B$4.47B$5.07B$8.90B
Dividend YieldN/A36.79%4.99%4.07%
P/E Ratio-7.7613.2787.8613.46
Price / Sales2.9244.831,228.8287.66
Price / CashN/A52.2739.5136.27
Price / Book-993.005.776.946.30
Net Income-$186.64M$13.76M$119.12M$225.93M
7 Day Performance13.75%-1.10%-1.84%-1.32%
1 Month Performance85.26%0.56%-3.65%0.60%
1 Year Performance-13.35%50.90%31.64%26.23%

Alphatec Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATEC
Alphatec
4.8003 of 5 stars
$9.93
+3.8%
$17.11
+72.3%
-12.7%$1.36B$482.26M-7.76700Analyst Forecast
MDXG
MiMedx Group
3.1237 of 5 stars
$9.06
-1.9%
$12.00
+32.5%
+26.4%$1.36B$321.48M16.47895
LMNX
Luminex
N/A$36.99
flat
N/AN/A$1.75B$417.40M115.591,325Analyst Forecast
GNMK
GenMark Diagnostics
N/A$24.04
flat
N/AN/A$1.76B$88.02M-29.32618Analyst Forecast
CRY
CryoLife
1.2837 of 5 stars
N/AN/AN/A$703.22M$253.23M596.201,200Analyst Forecast
ITGR
Integer
3.3345 of 5 stars
$133.37
-0.1%
$139.75
+4.8%
+48.9%$4.48B$1.60B41.1610,500Analyst Revision
Positive News
ATRC
AtriCure
3.4889 of 5 stars
$36.03
-0.9%
$43.11
+19.7%
-14.1%$1.77B$399.24M-43.411,200Positive News
IART
Integra LifeSciences
2.7938 of 5 stars
$22.93
+0.2%
$24.00
+4.7%
-40.7%$1.77B$1.54B0.003,946Positive News
OFIX
Orthofix Medical
1.3806 of 5 stars
$18.87
+0.7%
$23.00
+21.9%
+74.4%$715.75M$746.64M0.001,634
SRDX
Surmodics
4.2112 of 5 stars
$39.17
-0.1%
$50.00
+27.6%
+12.2%$559.12M$126.08M0.00376
ANGO
AngioDynamics
4.7568 of 5 stars
$6.74
+0.3%
$12.00
+78.0%
-1.9%$273.06M$303.91M-1.11748Positive News

Related Companies and Tools


This page (NASDAQ:ATEC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners